The Global Multiple Sclerosis Drugs Market size is expected to grow from USD 28.83 billion in 2022 to USD 41.95 billion by 2030, at a CAGR of 4.8% during the forecast period (2023-2030).
Multiple sclerosis (MS) is a chronic neurological ailment resulting from an unknown inflammatory procedure in the central worried system (CNS), resulting in multifocal demyelination and axonal loss usually...
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek